BioPharma Credit PLC

BOPCF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income$73$50$72$38
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$32$6-$17$31
Other Non-Cash-$7$8-$8$24
Operating Cash Flow$34$64$48$93
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$15$0$0$0
Inv. Sales/Matur.$85$39$39$0
Other Inv. Act.$0-$39$0$0
Investing Cash Flow$70-$0$39$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.-$51-$29-$77-$3
Dividends Paid-$54-$67-$108-$23
Other Fin. Act.$0$0$0$0
Financing Cash Flow-$105-$96-$185-$26
Forex Effect$0-$0$0-$0
Net Chg. in Cash-$1-$32-$98$67
Supplemental Information
Beg. Cash$6$37$135$68
End Cash$4$6$37$135
Free Cash Flow$34$64$48$93
BioPharma Credit PLC (BOPCF) Financial Statements & Key Stats | AlphaPilot